{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:05:28Z","timestamp":1792789528022,"version":"4.5.0"},"reference-count":232,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["202206010081"],"award-info":[{"award-number":["202206010081"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272996"],"award-info":[{"award-number":["82272996"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173014"],"award-info":[{"award-number":["82173014"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273460"],"award-info":[{"award-number":["82273460"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["KC-24249003"],"award-info":[{"award-number":["KC-24249003"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["21625105"],"award-info":[{"award-number":["21625105"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2020YFA0803200"],"award-info":[{"award-number":["2020YFA0803200"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007839","name":"Yunnan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007839","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007471","name":"Applied Basic Research Foundation of Yunnan Province","doi-asserted-by":"publisher","award":["202401AS070133"],"award-info":[{"award-number":["202401AS070133"]}],"id":[{"id":"10.13039\/100007471","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.drup.2025.101315","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:39:39Z","timestamp":1760539179000},"page":"101315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The role of tumor microenvironment and signaling pathways in regulating breast cancer stem cells: Implications for therapy resistance and tumor recurrence"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8078-1087","authenticated-orcid":false,"given":"Hongbo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayam","family":"Hamdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7773-5449","authenticated-orcid":false,"given":"Dewei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3045-2724","authenticated-orcid":false,"given":"Jianwei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2025.101315_bib1","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"P Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2025.101315_bib2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s12032-024-02347-z","article-title":"Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies","volume":"41","author":"Ali","year":"2024","journal-title":"Med. Oncol."},{"key":"10.1016\/j.drup.2025.101315_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/BD-190409","article-title":"Role of CD44 in breast cancer","volume":"39","author":"Al-Othman","year":"2020","journal-title":"Breast Dis."},{"key":"10.1016\/j.drup.2025.101315_bib4","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2174\/0113816128287325240329085055","article-title":"Impact of combination therapy with chemical drugs and megavoltage X-ray exposure on breast cancer stem cells' viability and proliferation of MCF-7 and MDA-MB-231 cell lines","volume":"30","author":"Banisharif Dehkordi","year":"2024","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.drup.2025.101315_bib5","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1172\/JCI59735","article-title":"Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis","volume":"122","author":"Battula","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drup.2025.101315_bib6","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","article-title":"Therapeutic targeting of the tumor microenvironment","volume":"11","author":"Bejarano","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.drup.2025.101315_bib7","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1158\/1541-7786.MCR-18-1044","article-title":"p21CIP1 promotes mammary Cancer-Initiating cells via activation of Wnt\/TCF1\/CyclinD1 signaling","volume":"17","author":"Benard","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.drup.2025.101315_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s42764-025-00150-2","article-title":"Increased NINJ1 expression in hormone receptor-positive breast tumors: implications for prognosis","volume":"6","author":"Berkel","year":"2025","journal-title":"Genome Instab. Dis."},{"key":"10.1016\/j.drup.2025.101315_bib9","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.stem.2023.05.007","article-title":"IFNgamma-induced stem-like state of cancer cells as a driver of metastatic progression following immunotherapy","volume":"30","author":"Beziaud","year":"2023","journal-title":"CELL STEM CELL"},{"key":"10.1016\/j.drup.2025.101315_bib10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00048.2019","article-title":"Diversity and biology of Cancer-Associated fibroblasts","volume":"101","author":"Biffi","year":"2021","journal-title":"PHYSIOL REV"},{"key":"10.1016\/j.drup.2025.101315_bib11","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"NAT MED"},{"key":"10.1016\/j.drup.2025.101315_bib12","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021108647","article-title":"Dynamic EMT: a multi-tool for tumor progression","volume":"40","author":"Brabletz","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.drup.2025.101315_bib13","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1038\/s41467-023-38097-1","article-title":"KK-LC-1 as a therapeutic target to eliminate ALDH(+) stem cells in triple negative breast cancer","volume":"14","author":"Bu","year":"2023","journal-title":"NAT COMMUN"},{"key":"10.1016\/j.drup.2025.101315_bib14","doi-asserted-by":"crossref","first-page":"898","DOI":"10.4236\/jct.2013.44101","article-title":"Nef-M1, a CXCR4 peptide antagonist, enhances apoptosis and inhibits primary tumor growth and metastasis in breast cancer","volume":"4","author":"Bumpers","year":"2013","journal-title":"J. Cancer Ther."},{"key":"10.1016\/j.drup.2025.101315_bib15","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1158\/0008-5472.CAN-24-0030","article-title":"Natural killer cell regulation of breast cancer stem cells mediates metastatic dormancy","volume":"84","author":"Bushnell","year":"2024","journal-title":"CANCER RES"},{"key":"10.1016\/j.drup.2025.101315_bib16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.biocel.2018.12.001","article-title":"Breast cancer stem cells: biology and therapeutic implications","volume":"107","author":"Butti","year":"2019","journal-title":"INT J. BIOCHEM CELL B"},{"key":"10.1016\/j.drup.2025.101315_bib17","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1002\/jcb.25972","article-title":"Metastatic breast cancer cells enter into dormant state and express cancer stem cells phenotype under chronic hypoxia","volume":"118","author":"Carcereri","year":"2017","journal-title":"J. CELL BIOCHEM"},{"key":"10.1016\/j.drup.2025.101315_bib18","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1158\/2326-6066.CIR-17-0675","article-title":"Disruption of IFN-I signaling promotes HER2\/Neu tumor progression and breast cancer stem cells","volume":"6","author":"Castiello","year":"2018","journal-title":"CANCER IMMUNOL RES"},{"key":"10.1016\/j.drup.2025.101315_bib19","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1038\/s41467-018-05220-6","article-title":"Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer","volume":"9","author":"Cazet","year":"2018","journal-title":"NAT COMMUN"},{"key":"10.1016\/j.drup.2025.101315_bib20","article-title":"Lipoic acid blocks autophagic flux and impairs cellular bioenergetics in breast cancer and reduces stemness","volume":"1868","author":"Chakravarti","year":"2022","journal-title":"BBAMOL BASIS DIS"},{"key":"10.1016\/j.drup.2025.101315_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118121","article-title":"Alpha lipoic acid modulates metabolic reprogramming in breast cancer stem cells enriched 3D spheroids by targeting phosphoinositide 3-kinase: in silico and in vitro insights","volume":"187","author":"Chakravarti","year":"2025","journal-title":"BIOMED PHARMACOTHER"},{"key":"10.1016\/j.drup.2025.101315_bib22","first-page":"204","article-title":"Carbonic anhydrase-IX score is a novel biomarker that predicts recurrence and survival for high-risk, nonmetastatic renal cell carcinoma: data from the phase III ARISER clinical trial","volume":"33","author":"Chamie","year":"2015","journal-title":"UROL ONCOLSEMIN ORI"},{"key":"10.1016\/j.drup.2025.101315_bib23","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/bcr3423","article-title":"The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem\/progenitors","volume":"15","author":"Chang","year":"2013","journal-title":"BREAST CANCER RES"},{"key":"10.1016\/j.drup.2025.101315_bib24","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41388-022-02574-6","article-title":"RAC1B function is essential for breast cancer stem cell maintenance and chemoresistance of breast tumor cells","volume":"42","author":"Chen","year":"2023","journal-title":"ONCOGENE"},{"key":"10.1016\/j.drup.2025.101315_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40169-018-0205-6","article-title":"Cytokines, breast cancer stem cells (BCSCs) and chemoresistance","volume":"7","author":"Chen","year":"2018","journal-title":"CLIN TRANSL MED"},{"key":"10.1016\/j.drup.2025.101315_bib26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12964-022-00888-2","article-title":"Tumor-associated macrophages promote epithelial-mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2\/AKT\/beta-catenin signaling","volume":"20","author":"Chen","year":"2022","journal-title":"CELL COMMUN SIGNAL"},{"key":"10.1016\/j.drup.2025.101315_bib27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"SIGNAL TRANSDUCT TAR"},{"key":"10.1016\/j.drup.2025.101315_bib28","doi-asserted-by":"crossref","first-page":"8709","DOI":"10.18632\/oncotarget.3325","article-title":"Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer","volume":"6","author":"Cho","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2025.101315_bib29","article-title":"Disruption of the NF-kappaB\/IL-8 signaling axis by sulconazole inhibits human breast cancer stem cell formation","volume":"8","author":"Choi","year":"2019","journal-title":"CELLSBASEL"},{"key":"10.1016\/j.drup.2025.101315_bib30","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s13046-018-0975-0","article-title":"Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid\/HIF-1alpha\/VEGF signalling in MCF-7 breast cancer cells","volume":"37","author":"Ciccone","year":"2018","journal-title":"J. EXP CLIN CANC RES"},{"key":"10.1016\/j.drup.2025.101315_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.689286","article-title":"The C-X-C motif chemokine ligand 1 sustains breast cancer stem cell Self-Renewal and promotes tumor progression and immune escape programs","volume":"9","author":"Ciummo","year":"2021","journal-title":"FRONT CELL DEV BIOL"},{"key":"10.1016\/j.drup.2025.101315_bib32","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41571-019-0293-2","article-title":"Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update","volume":"17","author":"Clara","year":"2020","journal-title":"NAT REV CLIN ONCOL"},{"key":"10.1016\/j.drup.2025.101315_bib33","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s41556-025-01663-4","article-title":"Dynamic regulation of integrin beta1 phosphorylation supports invasion of breast cancer cells","volume":"27","author":"Conway","year":"2025","journal-title":"NAT CELL BIOL"},{"key":"10.1016\/j.drup.2025.101315_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines6030077","article-title":"Breast cancer stem cells","volume":"6","author":"Crabtree","year":"2018","journal-title":"BIOMEDICINES"},{"key":"10.1016\/j.drup.2025.101315_bib35","doi-asserted-by":"crossref","first-page":"13820","DOI":"10.1073\/pnas.0905718106","article-title":"Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features","volume":"106","author":"Creighton","year":"2009","journal-title":"P NATL ACAD SCI USA"},{"key":"10.1016\/j.drup.2025.101315_bib36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10549-011-1692-y","article-title":"Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44(+) human breast cancer cells","volume":"133","author":"Croker","year":"2012","journal-title":"BREAST CANCER RES TR"},{"key":"10.1016\/j.drup.2025.101315_bib37","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.4161\/cc.10.22.17976","article-title":"Autophagy positively regulates the CD44(+) CD24(-\/low) breast cancer stem-like phenotype","volume":"10","author":"Cufi","year":"2011","journal-title":"CELL CYCLE"},{"key":"10.1016\/j.drup.2025.101315_bib38","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/978-981-15-0602-4_27","article-title":"Autophagy and the immune response","volume":"1206","author":"Cui","year":"2019","journal-title":"ADV EXP MED BIOL"},{"key":"10.1016\/j.drup.2025.101315_bib39","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.actbio.2022.08.024","article-title":"Reversal of epithelial-mesenchymal transition and inhibition of tumor stemness of breast cancer cells through advanced combined chemotherapy","volume":"152","author":"Cui","year":"2022","journal-title":"ACTA BIOMATER"},{"key":"10.1016\/j.drup.2025.101315_bib40","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2503081122","article-title":"Tumor-expressed GPNMB orchestrates Siglec-9(+) TAM polarization and EMT to promote metastasis in triple-negative breast cancer","volume":"122","author":"Dang Cao","year":"2025","journal-title":"P NATL ACAD SCI USA"},{"key":"10.1016\/j.drup.2025.101315_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154914","article-title":"Quinacrine inhibits HIF-1alpha\/VEGF-A mediated angiogenesis by disrupting the interaction between cMET and ABCG2 in patient-derived breast cancer stem cells","volume":"117","author":"Das","year":"2023","journal-title":"PHYTOMEDICINE"},{"key":"10.1016\/j.drup.2025.101315_bib42","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","article-title":"Autophagy and autophagy-related pathways in cancer","volume":"24","author":"Debnath","year":"2023","journal-title":"NAT REV MOL CELL BIO"},{"key":"10.1016\/j.drup.2025.101315_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051151","article-title":"Nanog signaling mediates radioresistance in ALDH-Positive breast cancer cells","volume":"20","author":"Dehghan Harati","year":"2019","journal-title":"INT J. MOL SCI"},{"key":"10.1016\/j.drup.2025.101315_bib44","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3724\/abbs.2025017","article-title":"Breast cancer-derived exosomal miR-105-5p facilitates the transformation of NFs into CAFs through LATS2-NF-kappaB signaling","volume":"57","author":"Ding","year":"2025","journal-title":"ACTA BIOCH BIOPH SIN"},{"key":"10.1016\/j.drup.2025.101315_bib45","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/jcb.27089","article-title":"Investigation of the effect of telomerase inhibitor BIBR1532 on breast cancer and breast cancer stem cells","volume":"120","author":"Dogan","year":"2019","journal-title":"J. CELL BIOCHEM"},{"key":"10.1016\/j.drup.2025.101315_bib46","doi-asserted-by":"crossref","first-page":"6634","DOI":"10.1158\/1078-0432.CCR-12-1436","article-title":"HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells","volume":"18","author":"Duru","year":"2012","journal-title":"CLIN CANCER RES"},{"key":"10.1016\/j.drup.2025.101315_bib47","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.canlet.2020.10.013","article-title":"ADAM protease inhibition overcomes resistance of breast cancer stem-like cells to gammadelta t cell immunotherapy","volume":"496","author":"Dutta","year":"2021","journal-title":"CANCER LETT"},{"key":"10.1016\/j.drup.2025.101315_bib48","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.2217\/epi-2021-0228","article-title":"The multiple faces of NANOG in cancer: a therapeutic target to chemosensitize therapy-resistant cancers","volume":"13","author":"Fatma","year":"2021","journal-title":"EPIGENOMICSUK"},{"key":"10.1016\/j.drup.2025.101315_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032520","article-title":"IRAK2 downregulation in Triple-Negative breast cancer cells decreases cellular growth in vitro and delays tumour progression in murine models","volume":"24","author":"Ferraro","year":"2023","journal-title":"INT J. MOL SCI"},{"key":"10.1016\/j.drup.2025.101315_bib50","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.18632\/oncotarget.1936","article-title":"Expression of stemness genes in primary breast cancer tissues: the role of SOX2 as a prognostic marker for detection of early recurrence","volume":"5","author":"Finicelli","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2025.101315_bib51","article-title":"Autophagy in breast cancer metastatic dormancy: tumor suppressing or tumor promoting functions?","author":"Flynn","year":"2019","journal-title":"J. Cancer Metastas.. Treat. 5"},{"key":"10.1016\/j.drup.2025.101315_bib52","doi-asserted-by":"crossref","first-page":"8537","DOI":"10.1038\/s41598-020-65250-3","article-title":"Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer","volume":"10","author":"Gagliardi","year":"2020","journal-title":"SCI REPUK"},{"key":"10.1016\/j.drup.2025.101315_bib53","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12964-023-01043-1","article-title":"c-MYC mediates the crosstalk between breast cancer cells and tumor microenvironment","volume":"21","author":"Gao","year":"2023","journal-title":"CELL COMMUN SIGNAL"},{"key":"10.1016\/j.drup.2025.101315_bib54","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1080\/09553002.2023.2232019","article-title":"The effects of PKI-402 on breast tumor models' radiosensitivity via dual inhibition of PI3K\/mTOR","volume":"99","author":"Gasimli","year":"2023","journal-title":"INT J. RADIAT BIOL"},{"key":"10.1016\/j.drup.2025.101315_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101227","article-title":"TGFbeta-activated asporin interacts with STMN1 to promote prostate cancer docetaxel chemoresistance and metastasis by upregulating the Wnt\/beta-catenin signaling pathway","volume":"81","author":"Ge","year":"2025","journal-title":"DRUG RESIST UPDATE"},{"key":"10.1016\/j.drup.2025.101315_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081058","article-title":"Pivotal role of AKT2 during dynamic phenotypic change of breast cancer stem cells","volume":"11","author":"Gener","year":"2019","journal-title":"CANCERS"},{"key":"10.1016\/j.drup.2025.101315_bib57","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","article-title":"Metastasis","volume":"186","author":"Gerstberger","year":"2023","journal-title":"CELL"},{"key":"10.1016\/j.drup.2025.101315_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156344","article-title":"Tamoxifen as a modulator of CXCL12-CXCR4-CXCR7 chemokine axis: a breast cancer and glioblastoma view","volume":"170","author":"Goncalves","year":"2023","journal-title":"CYTOKINE"},{"key":"10.1016\/j.drup.2025.101315_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202004504","article-title":"OTUD7B deubiquitinates LSD1 to govern its binding partner specificity, homeostasis, and breast cancer metastasis","volume":"8","author":"Gong","year":"2021","journal-title":"ADV SCI"},{"key":"10.1016\/j.drup.2025.101315_bib60","first-page":"1","article-title":"Phenyl boronic acid conjugated lipid nanoparticles for targeted delivery of gamma-secretase inhibitor to breast cancer cells","author":"Gummadi","year":"2025","journal-title":"DRUG DEV IND PHARM"},{"key":"10.1016\/j.drup.2025.101315_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.718721","article-title":"Breast cancer stem Cell-Derived ANXA6-Containing exosomes sustain paclitaxel resistance and cancer aggressiveness in breast cancer","volume":"9","author":"Guo","year":"2021","journal-title":"FRONT CELL DEV BIOL"},{"key":"10.1016\/j.drup.2025.101315_bib62","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.biopha.2016.03.024","article-title":"MicroR-760 suppresses cancer stem cell subpopulation and breast cancer cell proliferation and metastasis: by down-regulating NANOG","volume":"80","author":"Han","year":"2016","journal-title":"BIOMED PHARMACOTHER"},{"key":"10.1016\/j.drup.2025.101315_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106535","article-title":"Long non-coding RNA\/epithelial-mesenchymal transition axis in human cancers: tumorigenesis, chemoresistance, and radioresistance","volume":"186","author":"Hashemi","year":"2022","journal-title":"PHARMACOL RES"},{"key":"10.1016\/j.drup.2025.101315_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002353","article-title":"Targeted inhibition of wnt signaling with a clostridioides difficile toxin b fragment suppresses breast cancer tumor growth","volume":"21","author":"He","year":"2023","journal-title":"PLOS BIOL"},{"key":"10.1016\/j.drup.2025.101315_bib65","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13402-010-0007-3","article-title":"Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer","volume":"34","author":"Heerma Van Voss","year":"2011","journal-title":"CELL ONCOL"},{"key":"10.1016\/j.drup.2025.101315_bib66","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1124\/mol.113.086140","article-title":"Overexpression of Mcl-1 confers multidrug resistance, whereas topoisomerase IIbeta downregulation introduces mitoxantrone-specific drug resistance in acute myeloid leukemia","volume":"84","author":"Hermanson","year":"2013","journal-title":"MOL PHARMACOL"},{"key":"10.1016\/j.drup.2025.101315_bib67","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1182\/blood-2013-03-493924","article-title":"The spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization","volume":"123","author":"Hoellenriegel","year":"2014","journal-title":"BLOOD"},{"key":"10.1016\/j.drup.2025.101315_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.72","article-title":"A CD44v(+) subpopulation of breast cancer stem-like cells with enhanced lung metastasis capacity","volume":"8","author":"Hu","year":"2017","journal-title":"CELL DEATH DIS"},{"key":"10.1016\/j.drup.2025.101315_bib69","first-page":"248","article-title":"The emerging role of ADAM 12 regulates Epithelial-mesenchymal transition by activating the Wnt\/beta-catenin signaling pathway in colorectal cancer","volume":"20","author":"Huang","year":"2025","journal-title":"RECENT PAT ANTICANC"},{"key":"10.1016\/j.drup.2025.101315_bib70","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1158\/1078-0432.CCR-18-0461","article-title":"Reciprocal network between cancer Stem-Like cells and macrophages facilitates the progression and androgen deprivation therapy resistance of prostate cancer","volume":"24","author":"Huang","year":"2018","journal-title":"CLIN CANCER RES"},{"key":"10.1016\/j.drup.2025.101315_bib71","doi-asserted-by":"crossref","first-page":"16996","DOI":"10.18632\/oncotarget.24580","article-title":"Small molecule CXCR4 antagonists block the HIV-1 Nef\/CXCR4 axis and selectively initiate the apoptotic program in breast cancer cells","volume":"9","author":"Huang","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2025.101315_bib72","doi-asserted-by":"crossref","first-page":"17039","DOI":"10.1038\/cddiscovery.2017.39","article-title":"BMP-2 induces EMT and breast cancer stemness through rb and CD44","volume":"3","author":"Huang","year":"2017","journal-title":"CELL DEATH DISCOV"},{"key":"10.1016\/j.drup.2025.101315_bib73","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12935-022-02653-4","article-title":"Functional interplay between long non-coding RNAs and breast CSCs","volume":"22","author":"Hussen","year":"2022","journal-title":"CANCER CELL INT"},{"key":"10.1016\/j.drup.2025.101315_bib74","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.juro.2012.03.113","article-title":"Systemic buffers inhibit carcinogenesis in TRAMP mice","volume":"188","author":"Ibrahim-Hashim","year":"2012","journal-title":"J. Urol."},{"key":"10.1016\/j.drup.2025.101315_bib75","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1126\/science.1210597","article-title":"Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine","volume":"333","author":"Ito","year":"2011","journal-title":"SCIENCE"},{"key":"10.1016\/j.drup.2025.101315_bib76","doi-asserted-by":"crossref","first-page":"17591","DOI":"10.18632\/oncotarget.7540","article-title":"The multifaceted role of autophagy in tumor evasion from immune surveillance","volume":"7","author":"Janji","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2025.101315_bib77","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1186\/s12967-025-06638-5","article-title":"PYGO1 drives gastric cancer progression via the ITGB1\/CD47 axis and is therapeutically targeted by pentagalloylglucose","volume":"23","author":"Jia","year":"2025","journal-title":"J. TRANSL MED"},{"key":"10.1016\/j.drup.2025.101315_bib78","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10549-018-05085-9","article-title":"Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer","volume":"174","author":"Joseph","year":"2019","journal-title":"BREAST CANCER RES TR"},{"key":"10.1016\/j.drup.2025.101315_bib79","doi-asserted-by":"crossref","first-page":"8278","DOI":"10.3390\/curroncol30090601","article-title":"An overview of CD133 as a functional unit of prognosis and treatment resistance in glioblastoma","volume":"30","author":"Joyce","year":"2023","journal-title":"CURR ONCOL"},{"key":"10.1016\/j.drup.2025.101315_bib80","doi-asserted-by":"crossref","first-page":"5266","DOI":"10.1097\/MS9.0000000000002270","article-title":"Concise review: breast cancer stems cells and their role in metastases","volume":"86","author":"Kamalabadi Farahani","year":"2024","journal-title":"ANN MED SURG"},{"key":"10.1016\/j.drup.2025.101315_bib81","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aau8544","article-title":"Chronic TGF-beta exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition","volume":"12","author":"Katsuno","year":"2019","journal-title":"SCI SIGNAL"},{"key":"10.1016\/j.drup.2025.101315_bib82","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1074\/jbc.RA119.010252","article-title":"Extracellular domains I and II of cell-surface glycoprotein CD44 mediate its trans-homophilic dimerization and tumor cluster aggregation","volume":"295","author":"Kawaguchi","year":"2020","journal-title":"J. BIOL CHEM"},{"key":"10.1016\/j.drup.2025.101315_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25073932","article-title":"Molecular research and treatment of breast cancer 2.0","volume":"25","author":"Kawiak","year":"2024","journal-title":"INT J. MOL SCI"},{"key":"10.1016\/j.drup.2025.101315_bib84","article-title":"CD133-Dependent activation of phosphoinositide 3-Kinase \/AKT\/Mammalian target of rapamycin signaling in melanoma progression and drug resistance","volume":"13","author":"Kharouf","year":"2024","journal-title":"CELLSBASEL"},{"key":"10.1016\/j.drup.2025.101315_bib85","first-page":"47","article-title":"Oct4 suppresses IR\u2011induced premature senescence in breast cancer cells through STAT3- and NF\u2011kappaB-mediated IL\u201124 production","volume":"53","author":"Kim","year":"2018","journal-title":"INT J. ONCOL"},{"key":"10.1016\/j.drup.2025.101315_bib86","doi-asserted-by":"crossref","first-page":"190","DOI":"10.21873\/invivo.13817","article-title":"Sertaconazole, an imidazole antifungal agent, suppresses the stemness of breast cancer cells by inhibiting Stat3 signaling","volume":"39","author":"Kim","year":"2025","journal-title":"VIVO"},{"key":"10.1016\/j.drup.2025.101315_bib87","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021108863","article-title":"Autophagy in major human diseases","volume":"40","author":"Klionsky","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.drup.2025.101315_bib88","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ctrv.2017.11.002","article-title":"Targeting the Wnt\/beta-catenin pathway in cancer: update on effectors and inhibitors","volume":"62","author":"Krishnamurthy","year":"2018","journal-title":"CANCER TREAT REV"},{"key":"10.1016\/j.drup.2025.101315_bib89","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1038\/s41467-019-11640-9","article-title":"Autophagy inhibition elicits emergence from metastatic dormancy by inducing and stabilizing Pfkfb3 expression","volume":"10","author":"La Belle","year":"2019","journal-title":"NAT COMMUN"},{"key":"10.1016\/j.drup.2025.101315_bib90","article-title":"Preclinical and clinical trials of new treatment strategies targeting cancer stem cells in subtypes of breast cancer","volume":"12","author":"Landeros","year":"2023","journal-title":"CELLSBASEL"},{"key":"10.1016\/j.drup.2025.101315_bib91","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1126\/science.1218395","article-title":"Atg7 modulates p53 activity to regulate cell cycle and survival during metabolic stress","volume":"336","author":"Lee","year":"2012","journal-title":"SCIENCE"},{"key":"10.1016\/j.drup.2025.101315_bib92","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41392-023-01453-0","article-title":"Extracellular matrix-derived mechanical force governs breast cancer cell stemness and quiescence transition through integrin-DDR signaling","volume":"8","author":"Li","year":"2023","journal-title":"SIGNAL TRANSDUCT TAR"},{"key":"10.1016\/j.drup.2025.101315_bib93","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41419-023-05929-3","article-title":"Crosstalk between autophagy and CSCs: molecular mechanisms and translational implications","volume":"14","author":"Li","year":"2023","journal-title":"CELL DEATH DIS"},{"key":"10.1016\/j.drup.2025.101315_bib94","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.5301\/JBM.5000048","article-title":"Stem cell marker aldehyde dehydrogenase 1 (ALDH1)-expressing cells are enriched in triple-negative breast cancer","volume":"28","author":"Li","year":"2013","journal-title":"INT J. BIOL MARKER"},{"key":"10.1016\/j.drup.2025.101315_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116524","article-title":"Corrigendum to \"curcumin inhibits the invasion and metastasis of triple negative breast cancer via Hedgehog\/Gli1 signaling pathway\" [J. Ethnopharmacol. 283 (2022) 114689]","volume":"312","author":"Li","year":"2023","journal-title":"J. ETHNOPHARMACOL"},{"key":"10.1016\/j.drup.2025.101315_bib96","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1158\/1078-0432.CCR-08-2372","article-title":"Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells","volume":"15","author":"Li","year":"2009","journal-title":"CLIN CANCER RES"},{"key":"10.1016\/j.drup.2025.101315_bib97","doi-asserted-by":"crossref","first-page":"146","DOI":"10.52601\/bpr.2023.220020","article-title":"M6A RNA methylation modification and tumor immune microenvironment in lung adenocarcinoma","volume":"9","author":"Li","year":"2023","journal-title":"Biophys. Rep."},{"key":"10.1016\/j.drup.2025.101315_bib98","article-title":"Ubiquitin-specific peptidase 22 controls integrin-dependent cancer cell stemness and metastasis","volume":"27","author":"Liu","year":"2024","journal-title":"ISCIENCE"},{"key":"10.1016\/j.drup.2025.101315_bib99","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1038\/s41418-022-00969-2","article-title":"Hypoxia-induced GLT8D1 promotes glioma stem cell maintenance by inhibiting CD133 degradation through N-linked glycosylation","volume":"29","author":"Liu","year":"2022","journal-title":"CELL DEATH DIFFER"},{"key":"10.1016\/j.drup.2025.101315_bib100","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa063994","article-title":"The prognostic role of a gene signature from tumorigenic breast-cancer cells","volume":"356","author":"Liu","year":"2007","journal-title":"N. ENGL J. MED"},{"key":"10.1016\/j.drup.2025.101315_bib101","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.stemcr.2013.11.009","article-title":"Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts","volume":"2","author":"Liu","year":"2014","journal-title":"STEM CELL REP"},{"key":"10.1016\/j.drup.2025.101315_bib102","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1158\/0008-5472.CAN-17-2761","article-title":"HER2 overexpression triggers an IL1alpha proinflammatory circuit to drive tumorigenesis and promote chemotherapy resistance","volume":"78","author":"Liu","year":"2018","journal-title":"CANCER RES"},{"key":"10.1016\/j.drup.2025.101315_bib103","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s40364-021-00331-7","article-title":"Advances in the DNA methylation hydroxylase TET1","volume":"9","author":"Liu","year":"2021","journal-title":"BIOMARK RES"},{"key":"10.1016\/j.drup.2025.101315_bib104","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1158\/2159-8290.CD-18-0065","article-title":"Homophilic CD44 interactions mediate tumor cell aggregation and polyclonal metastasis in Patient-Derived breast cancer models","volume":"9","author":"Liu","year":"2019","journal-title":"CANCER DISCOV"},{"key":"10.1016\/j.drup.2025.101315_bib105","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109144118","article-title":"HIF-1-regulated expression of calreticulin promotes breast tumorigenesis and progression through Wnt\/beta-catenin pathway activation","volume":"118","author":"Liu","year":"2021","journal-title":"P NATL ACAD SCI USA"},{"key":"10.1016\/j.drup.2025.101315_bib106","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.tips.2023.11.006","article-title":"Biomarkers and targeted therapy for cancer stem cells","volume":"45","author":"Liu","year":"2024","journal-title":"TRENDS PHARMACOL SCI"},{"key":"10.1016\/j.drup.2025.101315_bib107","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1038\/s41467-021-25552-0","article-title":"Long non-coding RNA NR2F1-AS1 induces breast cancer lung metastatic dormancy by regulating NR2F1 and DeltaNp63","volume":"12","author":"Liu","year":"2021","journal-title":"NAT COMMUN"},{"key":"10.1016\/j.drup.2025.101315_bib108","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.stem.2024.04.004","article-title":"Hallmarks of cancer stemness","volume":"31","author":"Loh","year":"2024","journal-title":"CELL STEM CELL"},{"key":"10.1016\/j.drup.2025.101315_bib109","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/j.celrep.2017.02.001","article-title":"Chemotherapy-Induced Ca(2+) release stimulates breast cancer stem cell enrichment","volume":"18","author":"Lu","year":"2017","journal-title":"CELL REP"},{"key":"10.1016\/j.drup.2025.101315_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109757","article-title":"HIF-1 recruits NANOG as a coactivator for TERT gene transcription in hypoxic breast cancer stem cells","volume":"36","author":"Lu","year":"2021","journal-title":"CELL REP"},{"key":"10.1016\/j.drup.2025.101315_bib111","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1172\/JCI138577","article-title":"Chemotherapy-induced S100A10 recruits KDM6A to facilitate OCT4-mediated breast cancer stemness","volume":"130","author":"Lu","year":"2020","journal-title":"J. CLIN INVEST"},{"key":"10.1016\/j.drup.2025.101315_bib112","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1038\/onc.2013.209","article-title":"The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis","volume":"33","author":"Lu","year":"2014","journal-title":"ONCOGENE"},{"key":"10.1016\/j.drup.2025.101315_bib113","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12943-024-01975-3","article-title":"LINC00115 promotes chemoresistant breast cancer stem-like cell stemness and metastasis through SETDB1\/PLK3\/HIF1alpha signaling","volume":"23","author":"Luo","year":"2024","journal-title":"MOL CANCER"},{"key":"10.1016\/j.drup.2025.101315_bib114","doi-asserted-by":"crossref","DOI":"10.1172\/JCI171166","article-title":"ZMYND8 protects breast cancer stem cells against oxidative stress and ferroptosis through activation of NRF2","volume":"134","author":"Luo","year":"2024","journal-title":"J. CLIN INVEST"},{"key":"10.1016\/j.drup.2025.101315_bib115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cmet.2018.06.006","article-title":"Targeting breast cancer stem cell state equilibrium through modulation of redox signaling","volume":"28","author":"Luo","year":"2018","journal-title":"CELL METAB"},{"key":"10.1016\/j.drup.2025.101315_bib116","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s40824-023-00465-9","article-title":"A polymeric nanocarrier that eradicates breast cancer stem cells and delivers chemotherapeutic drugs","volume":"27","author":"Lv","year":"2023","journal-title":"BIOMATER RES"},{"key":"10.1016\/j.drup.2025.101315_bib117","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.canlet.2014.06.022","article-title":"Enriched CD44(+)\/CD24(-) population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC)","volume":"353","author":"Ma","year":"2014","journal-title":"CANCER LETT"},{"key":"10.1016\/j.drup.2025.101315_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155418","article-title":"Scutellarin, a flavonoid compound from scutellaria barbata, suppresses growth of breast cancer stem cells in vitro and in tumor-bearing mice","volume":"128","author":"Ma","year":"2024","journal-title":"PHYTOMEDICINE"},{"key":"10.1016\/j.drup.2025.101315_bib119","doi-asserted-by":"crossref","first-page":"1729299","DOI":"10.1080\/2162402X.2020.1729299","article-title":"PD-L1 is overexpressed on breast cancer stem cells through notch3\/mTOR axis","volume":"9","author":"Mansour","year":"2020","journal-title":"ONCOIMMUNOLOGY"},{"key":"10.1016\/j.drup.2025.101315_bib120","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"MOL CANCER"},{"key":"10.1016\/j.drup.2025.101315_bib121","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/sj.bjc.6604953","article-title":"CD44 targeting reduces tumour growth and prevents post-chemotherapy relapse of human breast cancers xenografts","volume":"100","author":"Marangoni","year":"2009","journal-title":"BRIT J. CANCER"},{"key":"10.1016\/j.drup.2025.101315_bib122","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1158\/1078-0432.CCR-13-0595","article-title":"Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathway","volume":"19","author":"McClements","year":"2013","journal-title":"CLIN CANCER RES"},{"key":"10.1016\/j.drup.2025.101315_bib123","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1365-2249.2010.04167.x","article-title":"In vivo manipulation of Vgamma9Vdelta2 t cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients","volume":"161","author":"Meraviglia","year":"2010","journal-title":"CLIN EXP IMMUNOL"},{"key":"10.1016\/j.drup.2025.101315_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.899622","article-title":"Inflammatory breast cancer: the secretome of HCMV(+) Tumor-Associated macrophages enhances proliferation, invasion, colony formation, and expression of cancer stem cell markers","volume":"12","author":"Mohamed","year":"2022","journal-title":"FRONT ONCOL"},{"key":"10.1016\/j.drup.2025.101315_bib125","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/s44321-024-00088-0","article-title":"DUSP6 inhibition overcomes neuregulin\/HER3-driven therapy tolerance in HER2+ breast cancer","volume":"16","author":"Momeny","year":"2024","journal-title":"EMBO MOL MED"},{"key":"10.1016\/j.drup.2025.101315_bib126","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1349-7006.2009.01151.x","article-title":"Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression","volume":"100","author":"Morimoto","year":"2009","journal-title":"CANCER SCI"},{"key":"10.1016\/j.drup.2025.101315_bib127","article-title":"Breast cancer stem cells upregulate IRF6 in stromal fibroblasts to induce stromagenesis","volume":"13","author":"Muralidharan","year":"2024","journal-title":"CELLSBASEL"},{"key":"10.1016\/j.drup.2025.101315_bib128","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1002\/ijc.28263","article-title":"CD133 expression in circulating tumor cells from breast cancer patients: potential role in resistance to chemotherapy","volume":"133","author":"Nadal","year":"2013","journal-title":"INT J. CANCER"},{"key":"10.1016\/j.drup.2025.101315_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.115887","article-title":"Deregulation of the CD44-NANOG-MDR1 associated chemoresistance pathways of breast cancer stem cells potentiates the anti-cancer effect of kaempferol in synergism with verapamil","volume":"437","author":"Nandi","year":"2022","journal-title":"TOXICOL APPL PHARM"},{"key":"10.1016\/j.drup.2025.101315_bib130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26010251","article-title":"The significance of aldehyde dehydrogenase 1 in cancers","volume":"26","author":"Nguyen","year":"2024","journal-title":"INT J. MOL SCI"},{"key":"10.1016\/j.drup.2025.101315_bib131","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1158\/1535-7163.MCT-18-0399","article-title":"ST8SIA1 regulates tumor growth and metastasis in TNBC by activating the FAK-AKT-mTOR signaling pathway","volume":"17","author":"Nguyen","year":"2018","journal-title":"MOL CANCER THER"},{"key":"10.1016\/j.drup.2025.101315_bib132","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23126813","article-title":"Targeting breast cancer stem cells using naturally occurring phytoestrogens","volume":"23","author":"Nguyen","year":"2022","journal-title":"INT J. MOL SCI"},{"key":"10.1016\/j.drup.2025.101315_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107153","article-title":"Tumor-associated macrophages-mediated CXCL8 infiltration enhances breast cancer metastasis: suppression by danirixin","volume":"95","author":"Nie","year":"2021","journal-title":"INT IMMUNOPHARMACOL"},{"key":"10.1016\/j.drup.2025.101315_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101170","article-title":"Autophagy in cancer development, immune evasion, and drug resistance","volume":"78","author":"Niu","year":"2025","journal-title":"DRUG RESIST UPDATE"},{"key":"10.1016\/j.drup.2025.101315_bib135","doi-asserted-by":"crossref","first-page":"231","DOI":"10.21873\/cgp.20498","article-title":"Correlation of GD2 biosynthesis enzymes with cancer stem cell markers in human breast cancer","volume":"22","author":"O'Neill","year":"2025","journal-title":"CANCER GENOM PROTEOM"},{"key":"10.1016\/j.drup.2025.101315_bib136","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","article-title":"Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion","volume":"121","author":"Orimo","year":"2005","journal-title":"CELL"},{"key":"10.1016\/j.drup.2025.101315_bib137","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23092193","article-title":"Targeting breast cancer stem cells to overcome treatment resistance","volume":"23","author":"Palomeras","year":"2018","journal-title":"MOLECULES"},{"key":"10.1016\/j.drup.2025.101315_bib138","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3892\/ol.2023.14107","article-title":"Downregulation of complement factor h attenuates the stemness of MDA\u2011MB\u2011231 breast cancer cells via modulation of the ERK and p38 signaling pathways","volume":"26","author":"Park","year":"2023","journal-title":"ONCOL LETT"},{"key":"10.1016\/j.drup.2025.101315_bib139","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1158\/0008-5472.CAN-05-0592","article-title":"Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic","volume":"65","author":"Patrawala","year":"2005","journal-title":"CANCER RES"},{"key":"10.1016\/j.drup.2025.101315_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107985","article-title":"Cell plasticity, senescence, and quiescence in cancer stem cells: biological and therapeutic implications","volume":"231","author":"Paul","year":"2022","journal-title":"PHARMACOL THERAPEUT"},{"key":"10.1016\/j.drup.2025.101315_bib141","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00005-012-0185-y","article-title":"Adaptive immune responses associated with breast cancer relapse","volume":"60","author":"Payne","year":"2012","journal-title":"ARCH IMMUNOL THER EX"},{"key":"10.1016\/j.drup.2025.101315_bib142","doi-asserted-by":"crossref","first-page":"506","DOI":"10.24272\/j.issn.2095-8137.2023.411","article-title":"Role of cancer stem cell ecosystem on breast cancer metastasis and related mouse models","volume":"45","author":"Peng","year":"2024","journal-title":"ZOOL RES"},{"key":"10.1016\/j.drup.2025.101315_bib143","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s43018-022-00339-4","article-title":"LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer","volume":"3","author":"Perez-Nunez","year":"2022","journal-title":"NAT CANCER"},{"key":"10.1016\/j.drup.2025.101315_bib144","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1080\/15548627.2017.1310356","article-title":"Autophagy in natural and therapy-driven anticancer immunosurveillance","volume":"13","author":"Pietrocola","year":"2017","journal-title":"AUTOPHAGY"},{"key":"10.1016\/j.drup.2025.101315_bib145","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41571-021-00588-9","article-title":"Harnessing cytokines and chemokines for cancer therapy","volume":"19","author":"Propper","year":"2022","journal-title":"NAT REV CLIN ONCOL"},{"key":"10.1016\/j.drup.2025.101315_bib146","doi-asserted-by":"crossref","first-page":"14925","DOI":"10.1073\/pnas.222491799","article-title":"Expression profiling of CD34+ hematopoietic stem\/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia","volume":"99","author":"Qian","year":"2002","journal-title":"P NATL ACAD SCI USA"},{"key":"10.1016\/j.drup.2025.101315_bib147","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1158\/2326-6066.CIR-22-0296","article-title":"Breast cancer stem Cell-Derived tumors escape from gammadelta T-cell immunosurveillance in vivo by modulating gammadelta T-cell ligands","volume":"11","author":"Raute","year":"2023","journal-title":"CANCER IMMUNOL RES"},{"key":"10.1016\/j.drup.2025.101315_bib148","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41419-025-07842-3","article-title":"Matrix stiffness regulates glucose-6-phosphate dehydrogenase expression to mediate sorafenib resistance in hepatocellular carcinoma through the ITGB1-PI3K\/AKT pathway","volume":"16","author":"Ren","year":"2025","journal-title":"CELL DEATH DIS"},{"key":"10.1016\/j.drup.2025.101315_bib149","article-title":"Role of hedgehog signaling in breast cancer: pathogenesis and therapeutics","volume":"8","author":"Riobo-Del Galdo","year":"2019","journal-title":"CELLSBASEL"},{"key":"10.1016\/j.drup.2025.101315_bib150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040979","article-title":"RhoC impacts the metastatic potential and abundance of breast cancer stem cells","volume":"7","author":"Rosenthal","year":"2012","journal-title":"PLOS ONE"},{"key":"10.1016\/j.drup.2025.101315_bib151","article-title":"Characterization and targeting of chemoresistant triple-negative breast cancer subtypes using amino-pyridine compounds","volume":"1871","author":"Ruiz-Martinez","year":"2025","journal-title":"BBAMOL BASIS DIS"},{"key":"10.1016\/j.drup.2025.101315_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106311","article-title":"STAT3-EMT axis in tumors: modulation of cancer metastasis, stemness and therapy response","volume":"182","author":"Sadrkhanloo","year":"2022","journal-title":"PHARMACOL RES"},{"key":"10.1016\/j.drup.2025.101315_bib153","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/stem.424","article-title":"Permanently blocked stem cells derived from breast cancer cell lines","volume":"28","author":"Sajithlal","year":"2010","journal-title":"STEM CELLS"},{"key":"10.1016\/j.drup.2025.101315_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104517","article-title":"Plumbagin inhibits cancer stem-like cells, angiogenesis and suppresses cell proliferation and invasion by targeting Wnt\/beta-catenin pathway in endocrine resistant breast cancer","volume":"150","author":"Sakunrangsit","year":"2019","journal-title":"PHARMACOL RES"},{"key":"10.1016\/j.drup.2025.101315_bib155","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1158\/0008-5472.CAN-16-2129","article-title":"Evolution of cancer Stem-like cells in Endocrine-Resistant metastatic breast cancers is mediated by stromal microvesicles","volume":"77","author":"Sansone","year":"2017","journal-title":"CANCER RES"},{"key":"10.1016\/j.drup.2025.101315_bib156","doi-asserted-by":"crossref","first-page":"1150774","DOI":"10.3389\/fphar.2023.1150774","article-title":"A small molecule inhibitor of Notch1 modulates stemness and suppresses breast cancer cell growth","volume":"14","author":"Saran","year":"2023","journal-title":"FRONT PHARMACOL"},{"key":"10.1016\/j.drup.2025.101315_bib157","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10549-024-07434-3","article-title":"CD133 expression is associated with less DNA repair, better response to chemotherapy and survival in ER-positive\/HER2-negative breast cancer","volume":"208","author":"Sato","year":"2024","journal-title":"BREAST CANCER RES TR"},{"key":"10.1016\/j.drup.2025.101315_bib158","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1158\/1078-0432.CCR-11-3326","article-title":"Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors","volume":"19","author":"Schott","year":"2013","journal-title":"CLIN CANCER RES"},{"key":"10.1016\/j.drup.2025.101315_bib159","doi-asserted-by":"crossref","first-page":"1683345","DOI":"10.1080\/2162402X.2019.1683345","article-title":"GD2-targeted chimeric antigen receptor t cells prevent metastasis formation by elimination of breast cancer stem-like cells","volume":"9","author":"Seitz","year":"2020","journal-title":"ONCOIMMUNOLOGY"},{"key":"10.1016\/j.drup.2025.101315_bib160","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/cbin.11978","article-title":"Significance of Oct-4 transcription factor as a pivotal therapeutic target for CD44(+) \/24(-) mammary tumor initiating cells: aiming at the root of the recurrence","volume":"47","author":"Sen","year":"2023","journal-title":"CELL BIOL INT"},{"key":"10.1016\/j.drup.2025.101315_bib161","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.actbio.2022.08.074","article-title":"Role of stiffness and physico-chemical properties of tumour microenvironment on breast cancer cell stemness","volume":"152","author":"Shah","year":"2022","journal-title":"ACTA BIOMATER"},{"key":"10.1016\/j.drup.2025.101315_bib162","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1038\/s41388-018-0370-5","article-title":"A SIRT1-centered circuitry regulates breast cancer stemness and metastasis","volume":"37","author":"Shi","year":"2018","journal-title":"ONCOGENE"},{"key":"10.1016\/j.drup.2025.101315_bib163","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00262-018-2226-9","article-title":"Regulatory mechanisms of PD-L1 expression in cancer cells","volume":"67","author":"Shi","year":"2018","journal-title":"CANCER IMMUNOL IMMUN"},{"key":"10.1016\/j.drup.2025.101315_bib164","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1158\/0008-5472.CAN-18-2636","article-title":"Spleen tyrosine Kinase-Mediated autophagy is required for Epithelial-Mesenchymal plasticity and metastasis in breast cancer","volume":"79","author":"Shinde","year":"2019","journal-title":"CANCER RES"},{"key":"10.1016\/j.drup.2025.101315_bib165","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CACANCER J. CLIN"},{"key":"10.1016\/j.drup.2025.101315_bib166","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10585-010-9321-4","article-title":"Evaluation of a CXCR4 antagonist in a xenograft mouse model of inflammatory breast cancer","volume":"27","author":"Singh","year":"2010","journal-title":"CLIN EXP METASTAS"},{"key":"10.1016\/j.drup.2025.101315_bib167","doi-asserted-by":"crossref","first-page":"8","DOI":"10.17305\/bjbms.2018.2756","article-title":"The role of the hedgehog signaling pathway in cancer: a comprehensive review","volume":"18","author":"Skoda","year":"2018","journal-title":"Bosn. J. BASIC MED"},{"key":"10.1016\/j.drup.2025.101315_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120050","article-title":"Emerging roles of CD133 in the treatment of gastric cancer, a novel stem cell biomarker and beyond","volume":"293","author":"Soleimani","year":"2022","journal-title":"LIFE SCI"},{"key":"10.1016\/j.drup.2025.101315_bib169","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/srep00362","article-title":"Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells","volume":"2","author":"Song","year":"2012","journal-title":"SCI REPUK"},{"key":"10.1016\/j.drup.2025.101315_bib170","doi-asserted-by":"crossref","first-page":"5039","DOI":"10.1158\/0008-5472.CAN-17-0072","article-title":"HDAC1 upregulation by NANOG promotes multidrug resistance and a Stem-like phenotype in immune edited tumor cells","volume":"77","author":"Song","year":"2017","journal-title":"CANCER RES"},{"key":"10.1016\/j.drup.2025.101315_bib171","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002966","article-title":"Interleukin-30 feeds breast cancer stem cells via CXCL10 and IL23 autocrine loops and shapes immune contexture and host outcome","volume":"9","author":"Sorrentino","year":"2021","journal-title":"J. IMMUNOTHER CANCER"},{"key":"10.1016\/j.drup.2025.101315_bib172","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20092069","article-title":"Mortalin (GRP75\/HSPA9) promotes survival and proliferation of thyroid carcinoma cells","volume":"20","author":"Starenki","year":"2019","journal-title":"INT J. MOL SCI"},{"key":"10.1016\/j.drup.2025.101315_bib173","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10549-019-05130-1","article-title":"PD-L1 expression in breast cancer: expression in subtypes and prognostic significance: a systematic review","volume":"174","author":"Stovgaard","year":"2019","journal-title":"BREAST CANCER RES TR"},{"key":"10.1016\/j.drup.2025.101315_bib174","doi-asserted-by":"crossref","first-page":"2271638","DOI":"10.1080\/15384047.2023.2271638","article-title":"PCBP1 regulates LIFR through FAM3C to maintain breast cancer stem cell self-renewal and invasiveness","volume":"24","author":"Streitfeld","year":"2023","journal-title":"CANCER BIOL THER"},{"key":"10.1016\/j.drup.2025.101315_bib175","doi-asserted-by":"crossref","first-page":"7765","DOI":"10.1007\/s13277-014-1816-1","article-title":"CXCL12-CXCR4 axis promotes the natural selection of breast cancer cell metastasis","volume":"35","author":"Sun","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.drup.2025.101315_bib176","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"CELL"},{"key":"10.1016\/j.drup.2025.101315_bib177","doi-asserted-by":"crossref","DOI":"10.1096\/fj.201801013R","article-title":"Up-regulation of miR-210 induced by a hypoxic microenvironment promotes breast cancer stem cells metastasis, proliferation, and self-renewal by targeting E-cadherin","author":"Tang","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.drup.2025.101315_bib178","first-page":"1084","article-title":"beta1,4-Galactosyltransferase v modulates breast cancer stem cells through Wnt\/beta-catenin signaling pathway","volume":"52","author":"Tang","year":"2020","journal-title":"CANCER RES TREAT"},{"key":"10.1016\/j.drup.2025.101315_bib179","doi-asserted-by":"crossref","first-page":"2208176","DOI":"10.1155\/2022\/2208176","article-title":"Chemokine\/GPCR Signaling-Mediated EMT in cancer metastasis","volume":"2022","author":"Tian","year":"2022","journal-title":"J. ONCOL"},{"key":"10.1016\/j.drup.2025.101315_bib180","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1074\/mcp.M112.023861","article-title":"Proteomic signatures of acquired letrozole resistance in breast cancer: suppressed estrogen signaling and increased cell motility and invasiveness","volume":"12","author":"Tilghman","year":"2013","journal-title":"MOL CELL Proteom."},{"key":"10.1016\/j.drup.2025.101315_bib181","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/stem.1849","article-title":"Nerve growth factor and proNGF simultaneously promote symmetric self-renewal, quiescence, and epithelial to mesenchymal transition to enlarge the breast cancer stem cell compartment","volume":"33","author":"Tomellini","year":"2015","journal-title":"STEM CELLS"},{"key":"10.1016\/j.drup.2025.101315_bib182","doi-asserted-by":"crossref","DOI":"10.3892\/or.2022.8316","article-title":"Dinaciclib inhibits the stemness of two subtypes of human breast cancer cells by targeting the FoxM1 and hedgehog signaling pathway","volume":"47","author":"Tsao","year":"2022","journal-title":"ONCOL REP"},{"key":"10.1016\/j.drup.2025.101315_bib183","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/s41374-020-0409-4","article-title":"miR-27a ameliorates chemoresistance of breast cancer cells by disruption of reactive oxygen species homeostasis and impairment of autophagy","volume":"100","author":"Ueda","year":"2020","journal-title":"LAB INVEST"},{"key":"10.1016\/j.drup.2025.101315_bib184","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.18632\/oncotarget.13814","article-title":"The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus","volume":"8","author":"Vazquez","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2025.101315_bib185","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1038\/s41467-018-04070-6","article-title":"Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence","volume":"9","author":"Vera-Ramirez","year":"2018","journal-title":"NAT COMMUN"},{"key":"10.1016\/j.drup.2025.101315_bib186","article-title":"Cancer stem cell in prostate cancer progression, metastasis and therapy resistance","volume":"1878","author":"Verma","year":"2023","journal-title":"BBAREV CANCER"},{"key":"10.1016\/j.drup.2025.101315_bib187","article-title":"Breast cancer","volume":"14","author":"Visvader","year":"2024","journal-title":"CSH PERSPECT MED"},{"key":"10.1016\/j.drup.2025.101315_bib188","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/cdd.2017.162","article-title":"IL6 blockade potentiates the anti-tumor effects of gamma-secretase inhibitors in Notch3-expressing breast cancer","volume":"25","author":"Wang","year":"2018","journal-title":"CELL DEATH DIFFER"},{"key":"10.1016\/j.drup.2025.101315_bib189","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/cac2.12351","article-title":"A non-metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11-mediated CD133 stability","volume":"42","author":"Wang","year":"2022","journal-title":"CANCER COMMUN"},{"key":"10.1016\/j.drup.2025.101315_bib190","article-title":"Targeting UBE2T suppresses breast cancer stemness through CBX6-mediated transcriptional repression of SOX2 and NANOG","volume":"611","author":"Wang","year":"2024","journal-title":"CANCER LETT"},{"key":"10.1016\/j.drup.2025.101315_bib191","doi-asserted-by":"crossref","first-page":"1472772","DOI":"10.3389\/fimmu.2024.1472772","article-title":"Advances in targeting tumor microenvironment for immunotherapy","volume":"15","author":"Wang","year":"2024","journal-title":"FRONT IMMUNOL"},{"key":"10.1016\/j.drup.2025.101315_bib192","doi-asserted-by":"crossref","first-page":"446","DOI":"10.7150\/ijbs.86085","article-title":"VEGFA\/NRP-1\/GAPVD1 axis promotes progression and cancer stemness of triple-negative breast cancer by enhancing tumor cell-macrophage crosstalk","volume":"20","author":"Wang","year":"2024","journal-title":"INT J. BIOL SCI"},{"key":"10.1016\/j.drup.2025.101315_bib193","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cmet.2017.11.001","article-title":"JAK\/STAT3-Regulated fatty acid beta-Oxidation is critical for breast cancer stem cell Self-Renewal and chemoresistance","volume":"27","author":"Wang","year":"2018","journal-title":"CELL METAB"},{"key":"10.1016\/j.drup.2025.101315_bib194","article-title":"Transformable self-assembling peptide nanoplatforms with tumor microenvironment responsiveness for tumor stem cell suppression and immunomodulation","volume":"33","author":"Wei","year":"2025","journal-title":"MATER TODAY BIO"},{"key":"10.1016\/j.drup.2025.101315_bib195","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.exphem.2012.11.004","article-title":"Plerixafor (AMD3100) induces prolonged mobilization of acute lymphoblastic leukemia cells and increases the proportion of cycling cells in the blood in mice","volume":"41","author":"Welschinger","year":"2013","journal-title":"EXP HEMATOL"},{"key":"10.1016\/j.drup.2025.101315_bib196","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4331\/wjbc.v6.i2.39","article-title":"Adipocyte activation of cancer stem cell signaling in breast cancer","volume":"6","author":"Wolfson","year":"2015","journal-title":"World J. Biol. Chem."},{"key":"10.1016\/j.drup.2025.101315_bib197","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.semcancer.2022.08.003","article-title":"STAT family of transcription factors in breast cancer: pathogenesis and therapeutic opportunities and challenges","volume":"86","author":"Wong","year":"2022","journal-title":"SEMIN CANCER BIOL"},{"key":"10.1016\/j.drup.2025.101315_bib198","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1038\/s41388-019-0703-z","article-title":"TGFbeta promotes breast cancer stem cell self-renewal through an ILEI\/LIFR signaling axis","volume":"38","author":"Woosley","year":"2019","journal-title":"ONCOGENE"},{"key":"10.1016\/j.drup.2025.101315_bib199","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1021\/acs.jafc.5b00002","article-title":"Targeting cancer stem cells in breast cancer: potential anticancer properties of 6-shogaol and pterostilbene","volume":"63","author":"Wu","year":"2015","journal-title":"J. AGR FOOD CHEM"},{"key":"10.1016\/j.drup.2025.101315_bib200","doi-asserted-by":"crossref","first-page":"1509675","DOI":"10.3389\/fpubh.2025.1509675","article-title":"Unveiling the impact of CD133 on cell cycle regulation in radio- and chemo-resistance of cancer stem cells","volume":"13","author":"Wu","year":"2025","journal-title":"FRONT PUBLIC HEALTH"},{"key":"10.1016\/j.drup.2025.101315_bib201","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/s41467-022-29018-9","article-title":"Cancer stem cell regulated phenotypic plasticity protects metastasized cancer cells from ferroptosis","volume":"13","author":"Wu","year":"2022","journal-title":"NAT COMMUN"},{"key":"10.1016\/j.drup.2025.101315_bib202","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12964-023-01068-6","article-title":"Paracrine secretion of IL8 by breast cancer stem cells promotes therapeutic resistance and metastasis of the bulk tumor cells","volume":"21","author":"Wu","year":"2023","journal-title":"CELL COMMUN SIGNAL"},{"key":"10.1016\/j.drup.2025.101315_bib203","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/bs.acr.2018.11.001","article-title":"Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy","volume":"141","author":"Xiang","year":"2019","journal-title":"ADV CANCER RES"},{"key":"10.1016\/j.drup.2025.101315_bib204","first-page":"431","article-title":"Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis","volume":"9","author":"Xu","year":"2016","journal-title":"ONCOTARGETS THER"},{"key":"10.1016\/j.drup.2025.101315_bib205","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12943-020-01276-5","article-title":"Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities","volume":"19","author":"Xu","year":"2020","journal-title":"MOL CANCER"},{"key":"10.1016\/j.drup.2025.101315_bib206","doi-asserted-by":"crossref","first-page":"eadf1128","DOI":"10.1126\/scitranslmed.adf1128","article-title":"Inhibition of VEGF binding to neuropilin-2 enhances chemosensitivity and inhibits metastasis in triple-negative breast cancer","volume":"15","author":"Xu","year":"2023","journal-title":"SCI TRANSL MED"},{"key":"10.1016\/j.drup.2025.101315_bib207","first-page":"199","article-title":"Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery","volume":"9","author":"Xu","year":"2014","journal-title":"CHEMASIAN J."},{"key":"10.1016\/j.drup.2025.101315_bib208","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41420-022-00968-9","article-title":"A positive feedback loop: RAD18-YAP-TGF-beta between triple-negative breast cancer and macrophages regulates cancer stemness and progression","volume":"8","author":"Yan","year":"2022","journal-title":"CELL DEATH DISCOV"},{"key":"10.1016\/j.drup.2025.101315_bib209","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s13046-018-0925-x","article-title":"HIF-2alpha promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating wnt and notch pathways","volume":"37","author":"Yan","year":"2018","journal-title":"J. EXP CLIN CANC RES"},{"key":"10.1016\/j.drup.2025.101315_bib210","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s12032-014-0352-6","article-title":"Increased drug resistance in breast cancer by tumor-associated macrophages through IL-10\/STAT3\/bcl-2 signaling pathway","volume":"32","author":"Yang","year":"2015","journal-title":"MED ONCOL"},{"key":"10.1016\/j.drup.2025.101315_bib211","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101078","article-title":"Targeted dual degradation of HER2 and EGFR obliterates oncogenic signaling, overcomes therapy resistance, and inhibits metastatic lesions in HER2-positive breast cancer models","volume":"74","author":"Yang","year":"2024","journal-title":"DRUG RESIST UPDATE"},{"key":"10.1016\/j.drup.2025.101315_bib212","article-title":"Breast cancer treatment strategies targeting the tumor microenvironment: how to convert \"cold\" tumors to \"hot\" tumors","volume":"25","author":"Yang","year":"2024","journal-title":"INT J. MOL SCI"},{"key":"10.1016\/j.drup.2025.101315_bib213","first-page":"20230171","article-title":"Tumor cell membrane-based vaccines: a potential boost for cancer immunotherapy","volume":"4","author":"Yang","year":"2024","journal-title":"Explor. (Beijing)"},{"key":"10.1016\/j.drup.2025.101315_bib214","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/A:1020576606004","article-title":"Retinoid, retinoic acid receptor beta and breast cancer","volume":"76","author":"Yang","year":"2002","journal-title":"BREAST CANCER RES TR"},{"key":"10.1016\/j.drup.2025.101315_bib215","doi-asserted-by":"crossref","first-page":"eabo5000","DOI":"10.1126\/sciadv.abo5000","article-title":"NARF is a hypoxia-induced coactivator for OCT4-mediated breast cancer stem cell specification","volume":"8","author":"Yang","year":"2022","journal-title":"SCI ADV"},{"key":"10.1016\/j.drup.2025.101315_bib216","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.ajpath.2021.12.006","article-title":"SETD5 regulates glycolysis in breast cancer Stem-Like cells and fuels tumor growth","volume":"192","author":"Yang","year":"2022","journal-title":"AM J. PATHOL"},{"key":"10.1016\/j.drup.2025.101315_bib217","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1158\/0008-5472.CAN-15-2946","article-title":"Autophagy differentially regulates distinct breast cancer Stem-like cells in murine models via EGFR\/Stat3 and Tgfbeta\/Smad signaling","volume":"76","author":"Yeo","year":"2016","journal-title":"CANCER RES"},{"key":"10.1016\/j.drup.2025.101315_bib218","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1186\/s12885-024-13143-3","article-title":"NSDHL contributes to breast cancer stem-like cell maintenance and tumor-initiating capacity through TGF-beta\/Smad signaling pathway in MCF-7 tumor spheroid","volume":"24","author":"Yoon","year":"2024","journal-title":"BMC CANCER"},{"key":"10.1016\/j.drup.2025.101315_bib219","first-page":"20230007","article-title":"Artificial intelligence in breast imaging: current situation and clinical challenges","volume":"3","author":"You","year":"2023","journal-title":"Explor. (Beijing)"},{"key":"10.1016\/j.drup.2025.101315_bib220","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1038\/s41467-019-13700-6","article-title":"TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription","volume":"10","author":"Yu","year":"2019","journal-title":"NAT COMMUN"},{"key":"10.1016\/j.drup.2025.101315_bib221","doi-asserted-by":"crossref","first-page":"1443422","DOI":"10.3389\/fphar.2024.1443422","article-title":"Effects of BYL-719 (alpelisib) on human breast cancer stem cells to overcome drug resistance in human breast cancer","volume":"15","author":"Yu","year":"2024","journal-title":"FRONT PHARMACOL"},{"key":"10.1016\/j.drup.2025.101315_bib222","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1101\/gad.319889.118","article-title":"CD44 splice isoform switching determines breast cancer stem cell state","volume":"33","author":"Zhang","year":"2019","journal-title":"GENE DEV"},{"key":"10.1016\/j.drup.2025.101315_bib223","first-page":"9078209","article-title":"Propofol reduced mammosphere formation of breast cancer stem cells via PD-L1\/Nanog in vitro","volume":"2019","author":"Zhang","year":"2019","journal-title":"OXID MED CELL LONGEV"},{"key":"10.1016\/j.drup.2025.101315_bib224","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101273","article-title":"The multifaceted contributions of cancer-associated fibroblasts to drug resistance in primary and metastatic tumors","volume":"82","author":"Zhang","year":"2025","journal-title":"DRUG RESIST UPDATE"},{"key":"10.1016\/j.drup.2025.101315_bib225","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13754","article-title":"Notch-1 regulates collective breast cancer cell migration by controlling intercellular junction and cytoskeletal organization","volume":"58","author":"Zhang","year":"2025","journal-title":"CELL PROLIFERAT"},{"key":"10.1016\/j.drup.2025.101315_bib226","doi-asserted-by":"crossref","first-page":"15085","DOI":"10.1021\/acs.jmedchem.5c01301","article-title":"Discovery of juglone derivatives as novel STAT3 inhibitors with potent suppression of cancer cell stemness against breast cancer","volume":"68","author":"Zhang","year":"2025","journal-title":"J. MED CHEM"},{"key":"10.1016\/j.drup.2025.101315_bib227","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.3892\/mmr.2016.5856","article-title":"The hedgehog signaling pathway is associated with poor prognosis in breast cancer patients with the CD44+\/CD24\u2011 phenotype","volume":"14","author":"Zhao","year":"2016","journal-title":"MOL MED REP"},{"key":"10.1016\/j.drup.2025.101315_bib228","article-title":"B-9-8, a novel harman dimer, reverses ABCG2-mediated chemotherapeutic drug resistance","author":"Zhao","year":"2025","journal-title":"RECENT PAT ANTICANC"},{"key":"10.1016\/j.drup.2025.101315_bib229","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1124\/mol.119.117978","article-title":"Wnt signaling and drug resistance in cancer","volume":"97","author":"Zhong","year":"2020","journal-title":"MOL PHARMACOL"},{"key":"10.1016\/j.drup.2025.101315_bib230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117064","article-title":"LAT1 transporter as a target for breast cancer diagnosis and therapy","volume":"283","author":"Zhou","year":"2025","journal-title":"EUR J. MED CHEM"},{"key":"10.1016\/j.drup.2025.101315_bib231","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s13287-024-03875-1","article-title":"Orai1 and Orai3 act through distinct signalling axes to promote stemness and tumorigenicity of breast cancer stem cells","volume":"15","author":"Zhuo","year":"2024","journal-title":"STEM CELL RES THER"},{"key":"10.1016\/j.drup.2025.101315_bib232","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.31278","article-title":"Exploring the interplay between triple-negative breast cancer stem cells and tumor microenvironment for effective therapeutic strategies","volume":"239","author":"Zou","year":"2024","journal-title":"J. CELL PHYSIOL"}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764625001189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764625001189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T22:01:39Z","timestamp":1773180099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764625001189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":232,"alternative-id":["S1368764625001189"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2025.101315","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of tumor microenvironment and signaling pathways in regulating breast cancer stem cells: Implications for therapy resistance and tumor recurrence","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2025.101315","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101315"}}